Predictive Clinical Model of Tumor Response After Chemoradiation in Rectal Cancer

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Sep 24

PMID 28938543

Citations 9

Authors

Marisa D Santos

Cristina Silva

Anabela Rocha

Carlos Nogueira

Fernando Castro-Pocas

Antonio Araujo

Eduarda Matos

Carina Pereira

Rui Medeiros

Carlos Lopes

Affiliations

Soon will be listed here.

Abstract

Conclusion: It seems possible to use pretreatment expression of blood and tissue biomarkers, and build a model of tumor response prediction to neoadjuvant chemoradiation in rectal cancer.

Citing Articles

Genetic Variations in Prostaglandin E Pathway Identified as Susceptibility Biomarkers for Gastric Cancer in an Intermediate Risk European Country.

Lopes C, Pereira C, Farinha M, Medeiros R, Dinis-Ribeiro M Int J Mol Sci. 2021; 22(2).

PMID: 33440718 PMC: 7827533. DOI: 10.3390/ijms22020648.

A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer.

Hammarstrom K, Imam I, Mezheyeuski A, Ekstrom J, Sjoblom T, Glimelius B Cancers (Basel). 2020; 13(1).

PMID: 33375133 PMC: 7792936. DOI: 10.3390/cancers13010016.

Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients.

Troncarelli Flores B, E Silva V, Abdallah E, Mello C, Silva M, Mendes G Cells. 2019; 8(7).

PMID: 31247977 PMC: 6679115. DOI: 10.3390/cells8070641.

Local environment in biopsy better predict the pathological response to neoadjuvant chemoradiotherapy in rectal cancer.

Huang Y, Lou X, Zhu Y, Wang Y, Zhang L, Liu H Biosci Rep. 2019; 39(3).

PMID: 30867256 PMC: 6434387. DOI: 10.1042/BSR20190003.

Targeted Next-Generation Sequencing Validates the Use of Diagnostic Biopsies as a Suitable Alternative to Resection Material for Mutation Screening in Colorectal Cancer.

Ham-Karim H, Ebili H, Manger K, Fadhil W, Ahmad N, Richman S Mol Diagn Ther. 2019; 23(3):383-393.

PMID: 30741375 DOI: 10.1007/s40291-019-00388-z.

References

Murono K, Kawai K, Tsuno N, Ishihara S, Yamaguchi H, Sunami E . Barium enema and CT volumetry for predicting pathologic response to preoperative chemoradiotherapy in rectal cancer patients. Dis Colon Rectum. 2014; 57(6):715-24. DOI: 10.1097/DCR.0000000000000070. View

Choi C, Kim W, Lee S, Park W . Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer. Radiat Oncol J. 2012; 30(3):99-107. PMC: 3496850. DOI: 10.3857/roj.2012.30.3.99. View

Dhadda A, Dickinson P, Zaitoun A, Gandhi N, Bessell E . Prognostic importance of Mandard tumour regression grade following pre-operative chemo/radiotherapy for locally advanced rectal cancer. Eur J Cancer. 2011; 47(8):1138-45. DOI: 10.1016/j.ejca.2010.12.006. View

Fu C, Tominaga O, Nagawa H, Nita M, Masaki T, Ishimaru G . Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients. Dis Colon Rectum. 1998; 41(1):68-74. DOI: 10.1007/BF02236898. View

Del Vecchio L, Pozzoni P, Andrulli S, Locatelli F . Inflammation and resistance to treatment with recombinant human erythropoietin. J Ren Nutr. 2005; 15(1):137-41. DOI: 10.1053/j.jrn.2004.09.024. View

Kurt A, Yanar F, Asoglu O, Balik E, Olgac V, Karanlik H . Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation. BMC Clin Pathol. 2013; 12:27. PMC: 3542157. DOI: 10.1186/1472-6890-12-27. View

Lee Y, Hsieh C, Chuang J . Prognostic significance of partial tumor regression after preoperative chemoradiotherapy for rectal cancer: a meta-analysis. Dis Colon Rectum. 2013; 56(9):1093-101. DOI: 10.1097/DCR.0b013e318298e36b. View

Kalady M, Campos-Lobato L, Stocchi L, Geisler D, Dietz D, Lavery I . Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg. 2009; 250(4):582-9. DOI: 10.1097/SLA.0b013e3181b91e63. View

Gavioli M, Losi L, Luppi G, Iacchetta F, Zironi S, Bertolini F . Preoperative therapy for lower rectal cancer and modifications in distance from anal sphincter. Int J Radiat Oncol Biol Phys. 2007; 69(2):370-5. DOI: 10.1016/j.ijrobp.2007.03.049. View

10.

Wouters B, Giaccia A, Denko N, Brown J . Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. Cancer Res. 1997; 57(21):4703-6. View

11.

Huh J, Lee J, Kim H . Pretreatment expression of 13 molecular markers as a predictor of tumor responses after neoadjuvant chemoradiation in rectal cancer. Ann Surg. 2013; 259(3):508-15. DOI: 10.1097/SLA.0b013e31829b3916. View

12.

El-Deiry W, Harper J, OConnor P, Velculescu V, Canman C, Jackman J . WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 1994; 54(5):1169-74. View

13.

Bahnassy A, Zekri A, El-Houssini S, El-Shehaby A, Mahmoud M, Abdallah S . Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol. 2004; 4:22. PMC: 524166. DOI: 10.1186/1471-230X-4-22. View

14.

Rullier E, Goffre B, Bonnel C, Zerbib F, Caudry M, Saric J . Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg. 2001; 234(5):633-40. PMC: 1422087. DOI: 10.1097/00000658-200111000-00008. View

15.

Lu Y, Yamagishi N, Yagi T, Takebe H . Mutated p21(WAF1/CIP1/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells. Oncogene. 1998; 16(6):705-12. DOI: 10.1038/sj.onc.1201585. View

16.

Dou X, Wang R, Yan H, Jiang S, Meng X, Zhu K . Circulating lymphocytes as predictors of sensitivity to preoperative chemoradiotherapy in rectal cancer cases. Asian Pac J Cancer Prev. 2013; 14(6):3881-5. DOI: 10.7314/apjcp.2013.14.6.3881. View

17.

Azria D, Bibeau F, Barbier N, Zouhair A, Lemanski C, Rouanet P . Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer. BMC Cancer. 2005; 5:62. PMC: 1185521. DOI: 10.1186/1471-2407-5-62. View

18.

Kuremsky J, Tepper J, McLeod H . Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2009; 74(3):673-88. DOI: 10.1016/j.ijrobp.2009.03.003. View

19.

Martin S, Heneghan H, Winter D . Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg. 2012; 99(7):918-28. DOI: 10.1002/bjs.8702. View

20.

Hur H, Kim N, Min B, Baik S, Lee K, Koom W . Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer?. Dis Colon Rectum. 2014; 57(5):592-601. DOI: 10.1097/DCR.0000000000000109. View